Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3900
+0.0314 (8.76%)
Sep 8, 2026, 9:34 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $14.63 million as of September 8, 2026. Its market cap has decreased by -85.53% in one year.
Market Cap
14.63M
Enterprise Value
5.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.39
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 14.63M, a decrease of -91.15%. That is a compound annual growth rate of -36.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 14.63M | -64.75% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 25.22M |
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |
| Oncotelic Therapeutics | 14.34M |
| Synlogic | 13.69M |
| Inhibitor Therapeutics | 12.87M |